Search Within

Advanced Practice Providers

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (153)
  2. Journal Article (79)
  3. Research Letter (3)
  4. Editorial (1)
  5. Miscellaneous (1)
Groups
  1. GSK Faculty (237)
  2. Department of Medicine (200)
  3. Nursing (196)
  4. Center for Hematologic Malignancies (145)
  5. Hematologic Malignancies, Division of (138)
  6. Sloan Kettering Institute Faculty (108)

More Groups

People
  1. Renier Brentjens (52)
  2. Elizabeth Halton (48)
  3. Jae Park (47)
  4. Isabelle Riviere (38)
  5. Richard O'Reilly (37)
  6. Maria Palomba (36)

More People

Years
  1. 2025 (2)
  2. 2024 (15)
  3. 2023 (13)
  4. 2022 (18)
  5. 2021 (19)
  6. 2020 (17)

More Years

Publications
  1. Blood (54)
  2. Journal of Clinical Oncology (45)
  3. Biology of Blood and Marrow Transplantation (14)
  4. Neuro-Oncology (13)
  5. Bone Marrow Transplantation (7)
  6. Cancer Research (7)

More Publications

Publishers
  1. American Society of Hematology (58)
  2. American Society of Clinical Oncology (46)
  3. Elsevier Inc. (22)
  4. American Association for Cancer Research (21)
  5. Oxford University Press (16)
  6. Nature Publishing Group (15)

More Publishers

Results (237)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Delayed onset subacute atypical hemolytic uremic syndrome (aHUS) post allogeneic stem cell transplantation (SCT)
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Scaradavou, A.; Allen, J.; Ruggiero, J.; Torok-Castanza, J.; Zakak, N.; O'Reilly, R. J.; Prockop, S. E.
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Meeting Abstract

    Malard, F.; Shah, G. L.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; van den Brink, M.; Perales, M. A.
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • A phase II study of radioimmunotherapy with intraventricular 131I-3F8 for medulloblastoma
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Humm, J.; Zanzonico, P.; Haque, S.; Dunkel, I.; Wolden, S.; Donzelli, M.; Goldman, D.; Lewis, J.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
    Journal Article

    Osorio, J. C.; Ni, A.; Chaft, J. E.; Pollina, R.; Kasler, M. K.; Stephens, D.; Rodriguez, C.; Cambridge, L.; Rizvi, H.; Wolchok, J. D.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy
    Journal Article

    Naidoo, J.; Wang, X.; Woo, K. M.; Iyriboz, T.; Halpenny, D.; Cunningham, J.; Chaft, J. E.; Segal, N. H.; Callahan, M. K.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP)
    Meeting Abstract

    Shoushtari, A. N.; Navid-Azarbaijani, P.; Friedman, C. F.; Panageas, K.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Campbell, S. C.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Toxicity associated with ipilimumab and nivolumab (Ipi plus Nivo) combination therapy in melanoma patients (pts) treated at a single-institution under an expanded-access program (EAP)
    Meeting Abstract

    Friedman, C. F.; Navid-Azarbaijani, P.; Shoushtari, A. N.; Campbell, S. C.; Callahan, M. K.; Momtaz, P.; Prempeh-Keteku, N. A.; Postow, M. A.; Shames, Y.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save